Dr. Emmanuel Ayturk Aydin, MD

Dr. Aydin practices at Valley Medical Services in Mahwah, New Jersey.

Dr. Aydin's NPI, 1174524045, was assigned on August 2, 2005. Dr. Aydin graduated from Istanbul University Istanbul Medical Faculty in 1986. Dr. Aydin holds New Jersey license 25MA06743400.

Dr. Aydin's primary practice is Valley Medical Services, at 1400 Macarthur Blvd, Mahwah, NJ 07430 in Bergen County. The practice phone is (201) 291-6086.

Dr. Aydin's primary practice is Valley Medical Services in Mahwah, New Jersey. Dr. Aydin is also affiliated with St. Joseph's University Medical Center. The medical group on file is Valley Medical Group. Dmand AI also links Dr. Aydin to 2 more hospitals, 2 group practices and clinics, 2 skilled nursing facilities, 2 medical groups, 1 home health agency and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aydin practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Aydin's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Aydin is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Aydin's licenses on file in 2 states: New Jersey and Pennsylvania.

Dmand AI lists acid reflux, acute sinusitis, acute skin infection, alzheimer's disease, arthritis, asthma, atrial fibrillation and flutter and bronchitis among the conditions Dr. Aydin treats.

CMS data shows 2,381 Medicare services from Dr. Aydin across 19 procedure codes in 2024, for 319 Medicare patients. Medicare paid $164,989 for them.

CMS counts 319 Medicare patients who saw Dr. Aydin in 2024. The largest group is 65 to 74, with 124 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aydin's median patient age at 70, with 54% women.

In 2024, Dr. Aydin wrote 11,005 Medicare Part D claims for 527 patients. 83% of them were for generic drugs. CMS names the drug for 10,067 of them, across 171 drugs with 11 or more claims each, at $928,062 in total drug cost. In 2023, CMS named 10,373 claims across 172 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Aydin for performance year 2024, reported through an alternative payment model (APM). Dr. Aydin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Aydin, published from 2024 to 2025. 2024 was the busiest year, with 2. The most frequent topics are Alzheimer Disease, Mice, Transgenic and tau Proteins.

CMS Open Payments shows 183 general payments to Dr. Aydin from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $754.

Dmand AI lists 1 award for Dr. Aydin, most recently CMS Stage 1 2012 in 2011.

Dr. Aydin graduated from Istanbul University Istanbul Medical Faculty in 1986.

Dr. Aydin is in network with 17 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.